ImmuPharma | Sustainability Performance
Focuses on the development of innovative therapeutics to address unmet medical needs, including treatments for autoimmune disorders and cancer.
1999
United Kingdom
1-10 employees
Pharmaceuticals
$100K - 500K in revenue
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#9966
Overallⓘ#1110
in United Kingdomⓘ#238
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- ImmuPharma's clinical trial results for its lead drug candidate faced mixed regulatory reception.
Reporting
Not reporting on Sustainability
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
1
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.